X. Baraliakos

Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-{alpha} antibody infliximab (2007)

Baraliakos, X., Listing, J., Brandt, J., Haibel, H., Rudwaleit, M., Sieper, J., ...

Objectives. Anti-tumour necrosis factor therapy with infliximab has been shown to improve signs and symptoms of patients with active ankylosing spondylitis (AS). The objective of this article was to...

Magnetic resonance imaging in ankylosing spondylitis (2007)

Zochling, J, Baraliakos, X, Hermann, K, Braun, J

MRI has been increasingly used as an imaging modality in patients with ankylosing spondylitis (AS) and other spondyloarthritides due to its capacity to identify both active inflammation and chronic...

Magnetic resonance imaging in ankylosing spondylitis (2007)

Zochling, J, Baraliakos, X, Hermann, K, Braun, J

MRI has been increasingly used as an imaging modality in patients with ankylosing spondylitis (AS) and other spondyloarthritides due to its capacity to identify both active inflammation and chronic...

Magnetic resonance imaging in ankylosing spondylitis (2007)

Zochling, J, Baraliakos, X, Hermann, K, Braun, J

Magnetic resonance imaging in ankylosing spondylitis (2007)

Zochling, J, Baraliakos, X, Hermann, K, Braun, J

MRI has been increasingly used as an imaging modality in patients with ankylosing spondylitis (AS) and other spondyloarthritides due to its capacity to identify both active inflammation and chronic...

Infection and work stress are potential triggers of ankylosing spondylitis (2006)

Zochling, J, Bohl-Buehler, MH, Baraliakos, X, Feldtkeller, E, Braun, J

The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms (2006)

Zochling, J, Bohl-Buehler, MH, Baraliakos, X, Feldtkeller, E, Braun, J

Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis: a population-based survey (2006)

Zochling, J, Bohl-Buehler, MH, Baraliakos, X, Feldtkeller, E, Braun, J

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial (2006)

Braun, J, Zochling, J, Baraliakos, X, Alten, R, Burmester, G, Grasedyck, K, ...

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept (2005)

Baraliakos, X, Davis, J, Tsuji, W, Braun, J

No abstract available.

Two-year follow-up results after re-administration of etanercept in active ankylosing spondylitis (2005)

Baraliakos, X, Brandt, J, Listing, J, Haibel, H, Rudwaleit, HM, Sieper, J, ...

No abstract available.

Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years (2005)

Baraliakos, X, Brandt, J, Listing, J, Sieper, J, Braun, J

No abstract available.

Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab (2005)

Baraliakos, X, Listing, J, Brandt, J, Rudwaleit, M, Sieper, J, Braun, J

No abstract available.

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab (2005)

Baraliakos, X, Listing, J, Rudwaleit, M, Brandt, J, Sieper, J, Braun, J

No abstract available.

Persistent clinical response to the anti-TNF-{alpha} antibody infliximab in patients with ankylosing spondylitis over 3 years (2005)

Braun, J., Baraliakos, X., Brandt, J., Listing, J., Zink, A., Alten, R., ...

Objective. Infliximab, a monoclonal antibody against tumour necrosis factor α (TNF-α), is approved in Europe for the treatment of patients with active ankylosing spondylitis (AS) who have responded...

Persistent clinical response to the anti-TNF-{alpha} antibody infliximab in patients with ankylosing spondylitis over 3 years (2005)

Braun, J., Baraliakos, X., Brandt, J., Listing, J., Zink, A., Alten, R., ...

Objective. Infliximab, a monoclonal antibody against tumour necrosis factor α (TNF-α), is approved in Europe for the treatment of patients with active ankylosing spondylitis (AS) who have responded...

Persistent clinical response to the anti-TNF-{alpha} antibody infliximab in patients with ankylosing spondylitis over 3 years (2005)

Braun, J., Baraliakos, X., Brandt, J., Listing, J., Zink, A., Alten, R., ...

Objective. Infliximab, a monoclonal antibody against tumour necrosis factor α (TNF-α), is approved in Europe for the treatment of patients with active ankylosing spondylitis (AS) who have responded...

Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab (2005)

Sieper, J., Baraliakos, X., Listing, J., Brandt, J., Haibel, H., Rudwaleit, M., ...

Objectives. Patients with ankylosing spondylitis (AS) benefit from anti-TNF therapy both on a clinical basis and as depicted by magnetic resonance imaging (MRI). It is not known whether spinal...

Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab (2005)

Sieper, J., Baraliakos, X., Listing, J., Brandt, J., Haibel, H., Rudwaleit, M., ...

Objectives. Patients with ankylosing spondylitis (AS) benefit from anti-TNF therapy both on a clinical basis and as depicted by magnetic resonance imaging (MRI). It is not known whether spinal...

Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems

Braun, J, Baraliakos, X, Golder, W, Hermann, K, Listing, J, Brandt, J, ...

Objectives: To compare conventional radiography and magnetic resonance imaging (MRI) for detection of chronic changes in the spine of patients with ankylosing spondylitis (AS).

Magnetic resonance imaging in ankylosing spondylitis

Zochling, J, Baraliakos, X, Hermann, K, Braun, J

Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging

Baraliakos, X, Landewe, R, Hermann, K, Listing, J, Golder, W, Brandt, J, ...

Background: Magnetic resonance imaging (MRI) is increasingly used to detect inflammation in the spine of patients with ankylosing spondylitis (AS).

Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences

Baraliakos, X, Hermann, K, Landewe, R, Listing, J, Golder, W, Brandt, J, ...

Objectives: To compare the performance of two different MRI sequences—T1 weighted, fat saturated, spin echo after application of contrast medium, and short τ inversion recovery (STIR)...

Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept

Rudwaleit, M, Baraliakos, X, Listing, J, Brandt, J, Sieper, J, Braun, J

Objective: To assess the changes in inflammatory lesions of the spine and the sacroiliac (SI) joints as detected by magnetic resonance imaging (MRI) in patients with ankylosing spondylitis (AS) and...

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab

Baraliakos, X, Listing, J, Rudwaleit, M, Brandt, J, Sieper, J, Braun, J

Background: Anti-tumour necrosis factor (TNF) treatment is clinically efficacious in patients with active ankylosing spondylitis (AS) and leads to improvement of spinal inflammation, as assessed by...

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

Braun, J, Zochling, J, Baraliakos, X, Alten, R, Burmester, G, Grasedyck, K, ...